Show simple item record

dc.contributor.authorReynolds, John V
dc.contributor.authorDonohoe, Claire L
dc.contributor.authorMcGillycuddy, Erin
dc.contributor.authorRavi, Naraymasamy
dc.contributor.authorO'Toole, Dermot
dc.contributor.authorO'Byrne, Ken
dc.contributor.authorHollywood, Donal
dc.date.accessioned2012-09-13T09:01:47Z
dc.date.available2012-09-13T09:01:47Z
dc.date.issued2012-05
dc.identifier.citationEvolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. 2012, 143 (5):1130-1137.e1 J. Thorac. Cardiovasc. Surg.en_GB
dc.identifier.issn1097-685X
dc.identifier.pmid22244551
dc.identifier.doi10.1016/j.jtcvs.2011.12.003
dc.identifier.urihttp://hdl.handle.net/10147/243783
dc.description.abstractModern series from high-volume esophageal centers report an approximate 40% 5-year survival in patients treated with curative intent and postoperative mortality rates of less than 4%. An objective analysis of factors that underpin current benchmarks within high-volume centers has not been performed.
dc.language.isoenen
dc.publisherElsevieren_GB
dc.rightsArchived with thanks to The Journal of thoracic and cardiovascular surgeryen_GB
dc.subjectCarcinoma, Squamous Cell/therapyen_GB
dc.subjectEsophageal Neoplasms/therapyen_GB
dc.subjectEsophagogastric Junction/surgeryen_GB
dc.subjectAdenocarcinoma/therapyen_GB
dc.subject.meshAdenocarcinoma
dc.subject.meshAge Factors
dc.subject.meshCarcinoma, Squamous Cell
dc.subject.meshChemoradiotherapy, Adjuvant
dc.subject.meshChi-Square Distribution
dc.subject.meshDisease-Free Survival
dc.subject.meshEsophageal Neoplasms
dc.subject.meshEsophagectomy
dc.subject.meshEsophagogastric Junction
dc.subject.meshGastrectomy
dc.subject.meshHospital Mortality
dc.subject.meshHospitals
dc.subject.meshHumans
dc.subject.meshIreland
dc.subject.meshKaplan-Meier Estimate
dc.subject.meshLymph Node Excision
dc.subject.meshMultivariate Analysis
dc.subject.meshNeoadjuvant Therapy
dc.subject.meshNeoplasm Invasiveness
dc.subject.meshNeoplasm Staging
dc.subject.meshProportional Hazards Models
dc.subject.meshProspective Studies
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.subject.meshTime Factors
dc.subject.meshTreatment Outcome
dc.titleEvolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.en_GB
dc.contributor.departmentDepartment of Surgery, St James's Hospital and Trinity College, Dublin, Ireland. reynoljv@tcd.ieen_GB
dc.identifier.journalThe Journal of thoracic and cardiovascular surgeryen_GB
dc.description.provinceLeinsteren
html.description.abstractModern series from high-volume esophageal centers report an approximate 40% 5-year survival in patients treated with curative intent and postoperative mortality rates of less than 4%. An objective analysis of factors that underpin current benchmarks within high-volume centers has not been performed.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record